Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W F Gattaz

Showing results (1-10 of 123) with videos related to

Pageof 13
Sort By:
Biological Psychiatry|January 15, 1992
Phospholipase A2 in schizophreniaW F Gattaz
Modern Problems of Pharmacopsychiatry|January 1, 1983
Platelet MAO activity in major psychosesW F Gattaz
Social Psychiatry and Psychiatric Epidemiology|July 1, 1988
Administrative influences on psychiatric diagnosisW F Gattaz
Biological Psychiatry|June 15, 1995
Does vitamin E prevent tardive dyskinesia?W F Gattaz
Psychopathology|January 1, 1991
Psychiatric aspects of male genital self-mutilationT Martin, W F Gattaz
Der Gynakologe|December 1, 1995
[Sex differences in schizophrenia]H Häfner, W F Gattaz
Psychopharmacology|January 1, 1993
Assessment of tardive dyskinesia by means of digital image processingW F Gattaz, C Büchel
European Archives of Psychiatry and Clinical Neuroscience|January 1, 1993
Auditory evoked potentials in schizophrenic patients before and during neuroleptic treatment. Relationship to psychopathological stateG Adler, W F Gattaz
European Archives of Psychiatry and Clinical Neuroscience|January 1, 1995
Intracerebral injection of phospholipase A2 inhibits dopamine-mediated behavior in rats: possible implications for schizophreniaJ Brunner, W F Gattaz
European Archives of Psychiatry and Clinical Neuroscience|January 1, 1993
Tardive dyskinesia: preclinical and clinical aspectsW F Gattaz, J Gerlach
Pageof 13

Showing results (1-10 of 123) with videos related to

Sort By:
Pageof 13
Biological Psychiatry|January 15, 1992
Phospholipase A2 in schizophreniaW F Gattaz
Modern Problems of Pharmacopsychiatry|January 1, 1983
Platelet MAO activity in major psychosesW F Gattaz
Social Psychiatry and Psychiatric Epidemiology|July 1, 1988
Administrative influences on psychiatric diagnosisW F Gattaz
Biological Psychiatry|June 15, 1995
Does vitamin E prevent tardive dyskinesia?W F Gattaz
Psychopathology|January 1, 1991
Psychiatric aspects of male genital self-mutilationT Martin, W F Gattaz
Der Gynakologe|December 1, 1995
[Sex differences in schizophrenia]H Häfner, W F Gattaz
Psychopharmacology|January 1, 1993
Assessment of tardive dyskinesia by means of digital image processingW F Gattaz, C Büchel
European Archives of Psychiatry and Clinical Neuroscience|January 1, 1993
Auditory evoked potentials in schizophrenic patients before and during neuroleptic treatment. Relationship to psychopathological stateG Adler, W F Gattaz
European Archives of Psychiatry and Clinical Neuroscience|January 1, 1995
Intracerebral injection of phospholipase A2 inhibits dopamine-mediated behavior in rats: possible implications for schizophreniaJ Brunner, W F Gattaz
European Archives of Psychiatry and Clinical Neuroscience|January 1, 1993
Tardive dyskinesia: preclinical and clinical aspectsW F Gattaz, J Gerlach
Pageof 13